Opposing effects of the basic helix-loop-helix transcription factor SCL on erythroid and monocytic differentiation

Blood

Volumn 87, Issue 1, 1996, Pages 102-111

  Hoang, Trang ^a   Paradis, Éric ^b   Brady, Gerard ^b   Billia, Filio ^b   Nakahara, Kenneth ^b   Iscove, Norman N ^b   Kirsch, Ilan R ^b  

^a CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID; FC RECEPTOR; GLYCOPHORIN; HELIX LOOP HELIX PROTEIN; HEMOGLOBIN; RNA; TRANSCRIPTION FACTOR;

ARTICLE; CELL DIFFERENTIATION; CHROMOSOME TRANSLOCATION; CLINICAL PROTOCOL; CONTROLLED STUDY; ERYTHROBLAST; ERYTHROID CELL; ERYTHROID PRECURSOR CELL; ERYTHROLEUKEMIA CELL; GENE EXPRESSION; HEMATOPOIESIS; HUMAN; HUMAN CELL; MONOCYTE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T CELL LEUKEMIA; TRANSCRIPTION REGULATION;

EID: 0030042608     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v87.1.102.102     Document Type: Article

References (48)

1. Weintraub H: The MyoD family and myogenesis: Redundancy, networks, and thresholds. Cell 75:1241, 1993
2. Begley CG, Aplan PD, Davey MP, Nakahara K, Tchorz K, Kurtzberg J, Hershfield MS, Haynes BF, Cohen DI, Waldmann TA, Kirsch IR: Chromosomal translocation in a human leukemic stem-cell line disrupts the T-cell antigen receptor delta-chain diversity region and results in a previously unreported fusion transcript. Proc Natl Acad Sci USA 86:2031, 1989
3. Begley CG, Aplan PD, Denning SM, Haynes BF, Waldmann TA, Kirsch IR: The gene SCL is expressed during early hematopoiesis and encodes a differentiation-related DNA-binding motif. Proc Natl Acad Sci USA 86:10128, 1989
4. Chen Q, Cheng JT, Tasi LH, Schneider N, Buchanan G, Carroll A, Crist W, Ozanne B, Siciliano MJ, Baer R: The tal gene undergoes chromosome translocation in T cell leukemia and potentially encodes a helix-loop-helix protein. EMBO J 9:415, 1990
5. Finger LR, Kagan J, Christopher G, Kurtzberg J, Hershfield MS, Nowell PC, Croce CM: Involvement of the TCL5 gene on human chromosome 1 in T-cell leukemia and melanoma. Proc Natl Acad Sci USA 86:5039, 1989
6. Aplan PD, Lombardi DP, Ginsberg AM, Cossman J, Bertness VL, Kirsch IR: Disruption of the human SCL locus by "illegitimate" V-(D)-J recombinase activity. Science 250:1426, 1990
7. Aplan PD, Lombardi DP, Reaman GH, Sather HN, Hammond GD, Kirsch IR: Involvement of the putative hematopoietic transcription factor SCL in T-cell acute lymphoblastic leukemia. Blood 79:1327, 1992
8. Aplan PD, Raimondi SC, Kirsch IR: Disruption of the SCL gene by a t(1;3) translocation in a patient with T cell acute lymphoblastic leukemia. J Exp Med 176:1303, 1992
9. Bernard O, Guglielmi P, Jonveaux P, Cherif D, Gisselbrecht S, Mauchauffe M, Berger R, Larsen CJ, Mathieu-Mahul D: Two distinct mechanisms for the SCL gene activation in the t(1;14) translocation of T-cell leukemias. Genes Chromosom Cancer 1:194, 1990
10. Brown L, Cheng JT, Chen Q, Siciliano MJ, Crist W, Buchanan G, Baer R. Site-specific recombination of the tal-1 gene is a common occurrence in human T cell leukemia. EMBO J 9:3343, 1990
11. Bernard O, Azogui O, Lecointe N, Mugneret F, Berger R, Larsen CJ, Mathieu-Mahul D: A third tal-1 promoter is specifically used in human T cell leukemias. J Exp Med 176:919, 1992
12. Hsu HL, Wadman I, Tsan JT, Baer R: Positive and negative transcriptional control by the TAL1 helix-loop-helix protein. Proc Natl Acad Sci USA 91:5947, 1994
13. Begley CG, Visvader J, Green AR, Aplan PD, Metcalf D, Kirsch IR, Gough NM: Molecular cloning and chromosomal localization of the murine homolog of the human helix-loop-helix gene SCL. Proc Natl Acad Sci USA 88:869, 1991
14. Aplan PD, Nakahara K, Orkin SH, Kirsch IR: The SCL gene product: A positive regulator of erythroid differentiation. EMBO J 11:4073, 1992
15. Pulford K, Lecointe N, Leroy-Viard K, Jones M, Mathieu-Mahul D, Mason DY: Expression of TAL-1 proteins in human tissues. Blood 85:675, 1995
16. Green AR, Salvaris E, Begley CG: Erythroid expression of the 'helix-loop-helix' gene, SCL. Oncogene 6:475, 1991
17. Kallianpur AR, Jordan JE, Brandt SJ: The SCL/TAL-1 gene is expressed in progenitors of both the hematopoietic and vascular systems during embryogenesis. Blood 83:1200, 1994
18. Hwang LY, Siegelman M, Davis L, Oppenheimer-Marks N, Baer R: Expression of the TAL1 proto-oncogene in cultured endothelial cells and blood vessels of the spleen. Oncogene 8:3043, 1993
19. Mouthon MA, Bernard O, Mitjavila MT, Romeo PH, Vainchenker W, Mathieu-Mahul D: Expression of tal-1 and GATA-binding proteins during human hematopoiesis. Blood 81:647, 1993
20. Green AR, Lints T, Visvader J, Harvey R, Begley CG: SCL is coexpressed with GATA-1 in hemopoietic cells but is also expressed in developing brain. Oncogene 7:653, 1992 [published erratum appears in Oncogene 7:1459, 1992]
21. Brady G, Barbara M, Iscove NN: Representative in vitro cDNA amplification from individual hemopoietic cells and colonies. Methods Mol Cell Biol 2:17, 1990
22. Brady G, Iscove NN: Amplified representative cDNA libraries from single cells, in Wassarman PM, DePamphilis ML (eds): Methods in Enzymology, vol 225. San Diego, CA, Academic Press, 1993, p 611
23. Brady G, Billia F, Knox J, Hoang T, Kirsch IR, Voura EB, Hawley RG, Cumming R, Buchwald M, Siminovitch K, Miyamoto N, Boehmelt G, Iscove NN: Analysis of gene expression in a complex differentiation hierarchy by global amplification of cDNA from single cells. Curr Biol 5:909, 1995
24. Trumper LH, Brady G, Bagg A, Gray D, Loke SL, Griesser H, Wagman R, Braziel R, Gascoyne RD, Vicini S, Iscove NN, Cossman J, Mak TW: Single-cell analysis of Hodgkin and Reed-Sternberg cells: Molecular heterogeneity of gene expression and p53 mutations. Blood 81:3097, 1993
25. Green AR, DeLuca E, Begley CG: Antisense SCL suppresses self-renewal and enhances spontaneous erythroid differentiation of the human leukaemic cell line K562. EMBO J 10:4153, 1991
26. Tanigawa T, Elwood N, Metcalf D, Cary D, DeLuca E, Nicola NA, Begley CG: The SCL gene product is regulated by and differentially regulates cytokine responses during myeloid leukemic cell differentiation. Proc Natl Acad Sci USA 90:7864, 1993
27. Tanigawa T, Nicola N, McArthur GA, Strasser A, Begley CG: Differential regulation of macrophage differentiation in response to leukemia inhibitory factor/oncostatin-M/interleukin-6: The effect of enforced expression of the SCL transcription factor. Blood 85:379, 1995
28. Voronova AF, Lee F. The E2A and tal-1 helix-loop-helix proteins associate in vivo and are modulated by Id proteins during interleukin 6-induced myeloid differentiation. Proc Natl Acad Sci USA 91:5952, 1994
29. Shivdasani RA, Mayer EL, Orkin SH: Absence of blood formation in mice lacking the T-cell leukaemia oncoprotein tal-1/SCL. Nature 373:432, 1995
30. Kitamura T, Tange T, Terasawa T, Chiba S, Kuwaki T, Miyagawa K, Piao YF, Miyazono K, Urabe A, Takaku F: Establishment and characterization of a unique human cell line that proliferates dependently on GM-CSF, IL-3, or erythropoietin. J Cell Physiol 140:323, 1989
31. Cáceres-Cortés J, Rajotte D, Dumouchel J, Haddad P, Hoang T: Product of the Steel locus suppresses apoptosis in hemopoietic cells. Comparison with pathways activated by granulocyte macrophage colony-stimulating factor. J Biol Chem 269:12084, 1994
32. + antiporter in suppression of apoptosis by granulocyte macrophage colony-stimulating factor and interleukin-3. J Biol Chem 267:9980, 1992
33. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156, 1987
34. Hoang T, Haman A, Goncalves O, Letendre F, Mathieu M, Wong GG, Clark SC: Interleukin 1 enhances growth factor-dependent proliferation of the clonogenic cells in acute myeloblastic leukemia and of normal human primitive hemopoietic precursors. J Exp Med 168:463, 1988
35. Liebhaber SA, Goussens MJ, Kan YW: Cloning and complete nucleotide sequence of human 5′α-globin gene. Proc Natl Acad Sci USA 77:7054, 1980
36. Tso JY, Sun XH, Kao TH, Reece KS, Wu R: Isolation and characterization of rat and human glyceraldehyde-3-phosphate dehydrogenase cDNAs: Genomic complexity and molecular evolution of the gene. Nucleic Acids Res 13:2485, 1985
37. Watt SM, Sala-Newby G, Hoang T, Gilmore DJ, Grunert F, Nagel G, Murdoch SJ, Tchilian E, Lennox ES, Waldmann H: CD66 identifies a neutrophil-specific epitope within the hematopoietic system that is expressed by members of the carcinoembryonic antigen family of adhesion molecules. Blood 78:63, 1991
38. Prasad SKS, Jordan JE, Koury MJ, Bondurant MC, Brandt SJ: Erythropoietin stimulates transcription of the RAL1/SCL gene and phosphorylation of its protein products. J Biol Chem 270:11603, 1995
39. Sposi NM, Zon LI, Carè A, Valtieri M, Testa U, Gabbianelli M, Mariani G, Bottera L, Mather C, Orkin SH, Peschle C: Cell cycle-dependent initiation and lineage-dependent abrogation of GATA-1 expression in pure differentiating hematopoietic progenitors. Proc Natl Acad Sci USA 89:6353, 1992
40. Voso MT, Burn TC, Wulf G, Lim B, Leone G, Tenen DG: Inhibition of hematopotesis by competitive binding of transcription factor PU.1. Proc Natl Acad Sci USA 91:7932, 1994
41. Leroyviard K, Vinit MA, Lecointe N, Jouault H, Hibner U, Romeo PH, Mathieu-Mahul D: Loss of Tal-1 protein activity induces premature apoptosis of Jurkat leukemic T cells upon medium depletion. EMBO J 14:2341, 1995
42. Cross MA, Heyworth CM, Murrell AM, Bockamp EO, Dexter TM, Green AR: Expression of lineage restricted transcription factors precedes lineage specific differentiation in a multipotent haemopoietic progenitor cell line. Oncogene 9:3013, 1994
43. Mignotte V, Navarro S, Eleouet JF, Zon LI, Romeo PH: The extinction of erythroid genes after tetradecanoylphorbol acetate treatment of erythroleukemic cells correlates with down-regulation of the tissue-specific factors NF-E1 and NF-E2. J Biol Chem 265:22090, 1990
44. Kreider BL, Benezra R, Rovera G, Kadesch T: Inhibition of myeloid differentiation by the helix-loop-helix protein Id. Science 255:1700, 1992
45. Lozzio CB, Lozzio BB: Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome. Blood 45:321, 1975
46. Warren AJ, Colledge WH, Carlton MB, Evans MJ, Smith AJ, Rabbitts TH: The oncogenic cysteine-rich LIM domain protein rbtn2 is essential for erythroid development. Cell 78:45, 1994
47. Lassar AB, Davis RL, Wright WE, Kadesch T, Murre C, Voronova A, Baltimore D, Weintraub H: Functional activity of myogenic HLH proteins requires hetero-oligomerization with E12/E47-like proteins in vivo. Cell 66:305, 1991
48. Kadesch T: Consequences of heteromeric interactions among helix-loop-helix proteins. Cell Growth Differ 4:49, 1993